Appointment
Reckitt Benckiser PLC
29 November 2000
29 November 2000
Reckitt Benckiser: Appointment of Chairman Designate
The Board of Reckitt Benckiser plc today announced the appointment of Dr Hakan
Mogren as Chairman Designate. Dr Mogren will become Non-Executive Chairman in
May 2001, succeeding Alan Dalby who, as previously announced, retires at the
conclusion of the Annual General Meeting. Dr Mogren is appointed a
Non-Executive Director and joins the Board of Reckitt Benckiser plc with
immediate effect ensuring a smooth transition over the next 6 months.
Dr Hakan Mogren is, and will remain, Deputy Chairman of AstraZeneca PLC having
been President and Chief Executive Officer of Astra AB from 1988 until the
merger with Zeneca Group PLC in 1999. He has played a leading role in the
integration of the two businesses, helping ensure that AstraZeneca has met the
ambitious goals set at the time of the merger, increasing its share of the
global pharmaceutical market. AstraZeneca PLC has group sales of £11.4bn, a
current market capitalization of £61bn and employs more than 50,000 people
worldwide.
Prior to Astra AB, he was President and Chief Executive Officer of AB Marabou
1977-88, a leading European food group ultimately sold to Philip Morris. He is
also Non-Executive Vice-Chairman of Gambro AB and a Non-Executive Director of
Investor AB. Dr Mogren is also Chairman of the Research Institute of
Industrial Economics. Dr Mogren, 56, is a Swedish national, resident in
London. He is a graduate of the Royal Institute of Technology, Stockholm, and
is a Doctor of Science in Biotechnology. He is married with two children.
Commenting on this announcement, Alan Dalby, Chairman of Reckitt Benckiser
plc, said today:
'I am delighted that we have attracted Hakan Mogren to be the next Chairman of
Reckitt Benckiser. His experience running two major international companies,
one in consumer goods and one in pharmaceuticals, will be a major resource to
the Company. He will bring the insights gained from another merger and from
the multi-cultural organizations of two highly successful businesses. I know
that I will be leaving the company in capable hands with Hakan and an
excellent executive management team.'
For Further Information
Tom Corran Reckitt Benckiser plc + 44 1753 746 548
Senior Vice President, Corporate
Communications & Investor Relations
Bobby Leach Shandwick + 44 207 329 0096
Note For Editors
Dr Hakan Mogren
Nationality Swedish
Age 56 (born 1944)
Career to date
1969 Graduated, The Royal Institute of Technology, Stockholm
1969-1977 Various positions in marketing and R&D, AB Marabou
1974 Doctor of Science in Biotechnology
1977-1988 President & CEO, AB Marabou
1988-1999 President & CEO, Astra AB
1999-present Deputy Chairman, AstraZeneca PLC
Currently Chairman of Research Institute of Industrial Economics
Non-Executive Vice-Chairman, Gambro AB
Non-Executive Director, Investor AB
Non-Executive Director, Marianne and Marcus Wallenberg Foundation
Awards Chevalier dans l'Ordre National de la Legion d'Honneur (1995)
King's Medal of the 12th dimension with the Ribbon of the Order of
the Seraphims for services to Swedish industry (1998)
Honorary Doctor of Science, Leicester University (1998)
Member of the Royal Swedish Academy of Engineering Sciences and the
Swedish Gastronomic Academy.
Reckitt Benckiser plc
Reckitt Benckiser is the world leader in household cleaning (excluding Laundry
Detergent) with a major presence in Health & Personal care. The Company,
formed through the merger in 1999 of Reckitt & Colman plc and Benckiser NV,
has net revenues £3.1bn and a current market capitalization of over £6bn,
placing it in the top 50 companies in the FTSE 100 index. Reckitt Benckiser
plc has its headquarters outside London, and is listed on the London Stock
Exchange. Reckitt Benckiser employs over 18,000 people worldwide in over 50
countries, selling its brands in around 180 countries.